CMS Not Making Hospitals Participate In CAR-T Study

By John Wilkerson / August 7, 2019 at 7:46 PM
Hospitals that administer the expensive new CAR-T gene therapy are not required to participate in a clinical registry or study aimed at determining whether real-world results mirror those from clinical trials used to get the cancer drugs approved, according to the national coverage determination CMS published Wednesday (Aug. 7) . Sources following the CAR-T decision said political appointees did not want to require so-called coverage with evidence development, and the nearly two-month delay in announcing the national coverage determination was...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.